Abbisko Therapeutics Announced the Entry into a Licensing Agreement for Pimicotinib (ABSK021) with Merck Read more
Vanda Pharmaceuticals Announces that FDA Accepts New Drug Application for Tradipitant for the Treatment of Gastroparesis Read more
Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment Read more
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio Read more
Novavax’s Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health Organization Read more
AmacaThera Closes Series A Extension to Advance Clinical Development of Long Acting, Localized, Non-Opioid Therapeutics to Improve Post-Surgery Patient Care Read more
PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target Read more
Boehringer Ingelheim and IBM collaborate to advance generative AI and foundation models for therapeutic antibody development Read more
AbbVie Announces FDA and EMA Updates for Epcoritamab (EPKINLY/TEPKINLY) for the Treatment of Relapsed/Refractory Follicular Lymphoma Read more